Syros Pharmaceuticals, Inc. Annual Return On Equity in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Syros Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2023.
  • Syros Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -2.75K %, a 2151% decline year-over-year.
  • Syros Pharmaceuticals, Inc. annual Return On Equity for 2023 was -283 %, a 162% decline from 2022.
  • Syros Pharmaceuticals, Inc. annual Return On Equity for 2022 was -108 %, a 46.9% decline from 2021.
  • Syros Pharmaceuticals, Inc. annual Return On Equity for 2021 was -73.5 %, a 39.8% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -283 -175 -162% Jan 1, 2023 Dec 31, 2023
2022 -108 -34.5 -46.9% Jan 1, 2022 Dec 31, 2022
2021 -73.5 +48.6 +39.8% Jan 1, 2021 Dec 31, 2021
2020 -122 -35.8 -41.5% Jan 1, 2020 Dec 31, 2020
2019 -86.3 -21.8 -33.8% Jan 1, 2019 Dec 31, 2019
2018 -64.5 +6.34 +8.96% Jan 1, 2018 Dec 31, 2018
2017 -70.8 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.